The Geneva Foundation is pleased to share our 2017 Annual Report. The report celebrates Geneva’s accomplishments and our growth over the past year, in support of our mission to advance military medicine for the benefit of U.S. service members and veterans, their families, and the global community.
In 2017, Geneva supported over 545 research programs in areas including Infectious Diseases, Oncology, Orthopedics, and Neurology. The organization continued to pursue innovative treatments for the Ebola virus, hantavirus, and malaria, working with researchers at federal laboratories and our collaborators in industry and academia. In addition, several new collaborations and programs were established, to include the 4D Biofabrication, Bioprinting, and Biomanufacturing Laboratory (4D Bio³) as part of Geneva’s expanding relationship with the Uniformed Services University (USU).
Thanks to our accomplished team of employees, researchers, and collaborating partners, Geneva managed over $53.4 million in total grant, contract, and award revenue – supporting more than 545 research programs and over 240 principal investigators at military treatment facilities and federal laboratories worldwide.
We are proud to have continued our investment in our employees and our leadership, who continually strive for excellence, are driven by our mission, and demonstrate Geneva’s values of Integrity, Superior Customer Service, Quality, Innovation, Teamwork, and Respect For All.
Thank you to all our partners – we are truly privileged to be sharing these successes with you. Together, we are shaping the future of military medicine.